• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺乳头状癌:30年组织学亚型临床病理回顾

Papillary carcinoma of thyroid: A 30-yr clinicopathological review of the histological variants.

作者信息

Lam Alfred King-Yin, Lo Chung-Yau, Lam Karen Siu-Ling

机构信息

Discipline of Pathology, School of Medicine, Griffith University, Gold Coast, Australia.

出版信息

Endocr Pathol. 2005 Winter;16(4):323-30. doi: 10.1385/ep:16:4:323.

DOI:10.1385/ep:16:4:323
PMID:16627919
Abstract

Many histological variants of PTC have been described and some are known to have prognostic significance. However, their relative frequencies and associated clinicopathological features in a large cohort of patients with PTC treated at a single institution have seldom been documented. We reclassified 1035 malignant thyroid tumors treated in a 30-yr study period, into variants of PTC according to current histological criteria and analyzed their features. Six hundred and fifty two patients (153 men; 499 women) with PTC were identified. PTC accounted for 72.8% of primary thyroid cancers. Conventional papillary carcinoma (n = 300) accounted for 46% of PTC and papillary microcarcinoma 27.8% (n = 181). The frequencies of the common histological variants were follicular (17.6%, n =115), tall cell (4%, n = 26), and diffuse sclerosing (1.8%, n = 12). Uncommon histological variants including solid (n = 5), diffuse follicular (n = 5), papillary carcinoma with focal insular component (n = 3), columnar cell (n = 2), papillary carcinoma with fasciitis-like stroma (n = 2), and oncocytic (n = 1) were also noted. Histological variants of PTC had different age presentation, tumor size, frequencies of lymph node metastases, calcification, metaplastic bone, and psammoma bodies, when compared with conventional PTC. We conclude that a high prevalence of different variants of PTC with distinct clinicopathological features can be documented. Recognition of these histological variants may be important for better management of patients with PTC.

摘要

甲状腺乳头状癌(PTC)有多种组织学变异类型,其中一些已知具有预后意义。然而,在单一机构接受治疗的大量PTC患者队列中,它们的相对频率及相关临床病理特征鲜有记录。我们将在30年研究期间治疗的1035例恶性甲状腺肿瘤,根据当前组织学标准重新分类为PTC变异类型,并分析其特征。共识别出652例PTC患者(153例男性;499例女性)。PTC占原发性甲状腺癌的72.8%。传统乳头状癌(n = 300)占PTC的46%,乳头状微小癌占27.8%(n = 181)。常见组织学变异类型的频率分别为滤泡状(17.6%,n = 115)、高细胞型(4%,n = 26)和弥漫硬化型(1.8%,n = 12)。还注意到一些罕见的组织学变异类型,包括实性(n = 5)、弥漫滤泡状(n = 5)、伴有局灶性岛状成分的乳头状癌(n = 3)、柱状细胞型(n = 2)、伴有筋膜炎样间质的乳头状癌(n = 2)和嗜酸细胞型(n = 1)。与传统PTC相比,PTC的组织学变异类型在发病年龄、肿瘤大小、淋巴结转移频率、钙化、化生骨和砂粒体方面存在差异。我们得出结论,不同临床病理特征的PTC变异类型具有较高的发生率。认识这些组织学变异类型可能对更好地管理PTC患者很重要。

相似文献

1
Papillary carcinoma of thyroid: A 30-yr clinicopathological review of the histological variants.甲状腺乳头状癌:30年组织学亚型临床病理回顾
Endocr Pathol. 2005 Winter;16(4):323-30. doi: 10.1385/ep:16:4:323.
2
Diffuse sclerosing variant of papillary thyroid carcinoma: a clinicopathologic and immunophenotypic analysis of 22 cases.甲状腺乳头状癌弥漫性硬化型:22例临床病理及免疫表型分析
Endocr Pathol. 2005 Winter;16(4):331-48. doi: 10.1385/ep:16:4:331.
3
Higher incidence of tall cell variant of papillary thyroid carcinoma in Graves' Disease.Graves 病中高细胞型甲状腺乳头状癌的发生率更高。
Thyroid. 2014 Feb;24(2):347-54. doi: 10.1089/thy.2013.0133. Epub 2013 Sep 11.
4
Clinicopathological profile of papillary carcinoma of thyroid: A 10-year experience in a tertiary care institute in North Karnataka, India.甲状腺乳头状癌的临床病理特征:印度北卡纳塔克邦一家三级医疗机构的10年经验。
Indian J Cancer. 2017 Jul-Sep;54(3):514-518. doi: 10.4103/ijc.IJC_337_17.
5
Bethesda classification is a valuable guide for fine needle aspiration reports and highly predictive especially for diagnosing aggressive variants of papillary thyroid carcinoma.贝塞斯达分类法是细针穿刺报告的重要指南,尤其对诊断甲状腺乳头状癌的侵袭性变体具有高度预测性。
Cytopathology. 2017 Aug;28(4):259-267. doi: 10.1111/cyt.12384. Epub 2016 Sep 25.
6
Papillary and Medullary Thyroid Carcinomas Presenting as Collision Tumors: A Case Series of 21 Cases at a Tertiary Care Cancer Center.甲状腺乳头和髓样癌作为碰撞瘤表现:一家三级癌症中心的 21 例病例系列。
Head Neck Pathol. 2021 Dec;15(4):1137-1146. doi: 10.1007/s12105-021-01323-7. Epub 2021 Apr 11.
7
Papillary thyroid carcinoma with different histological patterns.具有不同组织学模式的乳头状甲状腺癌。
Chang Gung Med J. 2011 Jan-Feb;34(1):23-34.
8
Strong expression of HBME-1 associates with high-risk clinicopathological factors of papillary thyroid carcinoma.HBME-1的强表达与甲状腺乳头状癌的高危临床病理因素相关。
Pathol Oncol Res. 2015 Jul;21(3):735-42. doi: 10.1007/s12253-014-9883-6. Epub 2015 Jan 11.
9
Pathologic study and clinical significance of Hürthle cell papillary thyroid carcinoma.嗜酸性细胞型甲状腺乳头状癌的病理研究及临床意义
Appl Immunohistochem Mol Morphol. 2004 Dec;12(4):329-37. doi: 10.1097/00129039-200412000-00007.
10
Clinicopathological Characteristics and Recurrence-Free Survival of Rare Variants of Papillary Thyroid Carcinomas in Korea: A Retrospective Study.韩国罕见型甲状腺乳头状癌的临床病理特征与无复发生存率:一项回顾性研究。
Endocrinol Metab (Seoul). 2021 Jun;36(3):619-627. doi: 10.3803/EnM.2021.974. Epub 2021 Jun 10.

引用本文的文献

1
Metastasis of follicular carcinoma of the thyroid gland to the mandible: A report of a rare case.甲状腺滤泡癌转移至下颌骨:1例罕见病例报告。
Dent Res J (Isfahan). 2025 Aug 25;22:35. doi: 10.4103/drj.drj_284_24. eCollection 2025.
2
LINC00162 silencing enhances sorafenib sensitivity and inhibits thyroid cancer cells progression through modulation of MAPK signaling and apoptosis.LINC00162基因沉默通过调节MAPK信号通路和细胞凋亡增强索拉非尼敏感性并抑制甲状腺癌细胞进展。
Sci Rep. 2025 Aug 13;15(1):29726. doi: 10.1038/s41598-025-12805-x.
3
Subtypes detection of papillary thyroid cancer from methylation assay via Deep Neural Network.

本文引用的文献

1
Warthin tumor-like variant of papillary thyroid carcinoma: a case with dedifferentiation (anaplastic changes) and aggressive biological behavior.甲状腺乳头状癌的沃辛瘤样变异型:一例伴有去分化(间变改变)及侵袭性生物学行为的病例。
Endocr Pathol. 2005 Spring;16(1):83-9. doi: 10.1385/ep:16:1:083.
2
Observer variation in the diagnosis of follicular variant of papillary thyroid carcinoma.甲状腺乳头状癌滤泡变体诊断中的观察者变异
Am J Surg Pathol. 2004 Oct;28(10):1336-40. doi: 10.1097/01.pas.0000135519.34847.f6.
3
Follicular variant of papillary thyroid carcinoma: a long-term follow-up.
通过深度神经网络从甲基化检测中进行甲状腺乳头状癌亚型检测。
Comput Struct Biotechnol J. 2025 Apr 29;27:1809-1817. doi: 10.1016/j.csbj.2025.04.034. eCollection 2025.
4
A case report and literature review of rare isolated metastatic papillary thyroid carcinoma in the orbit.眼眶罕见孤立性转移性甲状腺乳头状癌的病例报告及文献综述
Thyroid Res. 2024 Dec 2;17(1):25. doi: 10.1186/s13044-024-00216-5.
5
New Small-Molecule SERCA Inhibitors Enhance Treatment Efficacy in Lenvatinib-Resistant Papillary Thyroid Cancer.新型小分子 SERCA 抑制剂增强仑伐替尼耐药甲状腺乳头状癌的治疗效果。
Int J Mol Sci. 2024 Oct 3;25(19):10646. doi: 10.3390/ijms251910646.
6
MicroRNA Profiling in Papillary Thyroid Cancer.甲状腺乳头状癌中的 microRNA 谱分析。
Int J Mol Sci. 2024 Aug 29;25(17):9362. doi: 10.3390/ijms25179362.
7
High aggressiveness of papillary thyroid cancer: from clinical evidence to regulatory cellular networks.甲状腺乳头状癌的高侵袭性:从临床证据到调控细胞网络
Cell Death Discov. 2024 Aug 26;10(1):378. doi: 10.1038/s41420-024-02157-2.
8
To diagnose primary and secondary squamous cell carcinoma of the thyroid with ultrasound malignancy risk stratification.超声恶性风险分层诊断甲状腺原发性和继发性鳞状细胞癌。
Front Endocrinol (Lausanne). 2024 Mar 1;14:1238775. doi: 10.3389/fendo.2023.1238775. eCollection 2023.
9
Postoperative recurrence of diffuse sclerosing thyroid cancer in an adolescent patient: A case report.青少年弥漫硬化型甲状腺癌术后复发 1 例报告
Medicine (Baltimore). 2024 Feb 16;103(7):e37246. doi: 10.1097/MD.0000000000037246.
10
MicroRNA Expression Profiling-Potential Molecular Discrimination of Papillary Thyroid Carcinoma Subtypes.微小RNA表达谱分析——甲状腺乳头状癌亚型的潜在分子鉴别
Biomedicines. 2024 Jan 9;12(1):136. doi: 10.3390/biomedicines12010136.
甲状腺乳头状癌滤泡变体:长期随访
Arch Surg. 2003 Dec;138(12):1362-6. doi: 10.1001/archsurg.138.12.1362.
4
Controversies in papillary microcarcinoma of the thyroid.甲状腺微小乳头状癌的争议
Endocr Pathol. 2003 Fall;14(3):183-91. doi: 10.1007/s12022-003-0011-5.
5
Papillary microcarcinoma of the thyroid-Prognostic significance of lymph node metastasis and multifocality.甲状腺微小乳头状癌——淋巴结转移和多灶性的预后意义
Cancer. 2003 Jul 1;98(1):31-40. doi: 10.1002/cncr.11442.
6
An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid.甲状腺微小乳头状癌患者非手术治疗的观察性试验
Thyroid. 2003 Apr;13(4):381-7. doi: 10.1089/105072503321669875.
7
Diffuse sclerosing variant of papillary thyroid carcinoma--clinical features and outcome.甲状腺乳头状癌弥漫性硬化变异型——临床特征与预后
Eur J Surg Oncol. 2003 Jun;29(5):446-9. doi: 10.1016/s0748-7983(03)00005-2.
8
Frozen section in a cytological diagnosis of thyroid follicular neoplasm.甲状腺滤泡性肿瘤细胞学诊断中的冰冻切片
Laryngoscope. 2003 Mar;113(3):563-6. doi: 10.1097/00005537-200303000-00031.
9
Papillary carcinoma with subacute thyroiditis.伴有亚急性甲状腺炎的乳头状癌
Endocr Pathol. 2002 Fall;13(3):263-5. doi: 10.1007/s12022-002-0003-x.
10
Papillary thyroid carcinoma with fibromatosis-like stroma: a report of two cases.伴有纤维瘤病样间质的甲状腺乳头状癌:2例报告
Endocr Pathol. 2002 Fall;13(3):219-25. doi: 10.1385/ep:13:3:219.